Media-OutReach Newswire Health2Sync Completes an Oversubscribed Round of US$20 Million to Fuel Market Expansion and Prepares for Public Listing
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.